patients with uCTD and JH; in the groups with isolated dysplasia and combined
pathology, the differences
GAREEV, I.F.,
BEILERLI, O.A.,
ALIEV, G.M.,
PAVLOV, VALENTIN,
IZMAILOV, ADEL,
ZHANG, YIWEI,
LIANG, YANCHAO,
YANG, GUANG (2020) of lncRNAs and its targets in various
pathological conditions of a person is a rapidly developing field
or rehabilitation medicine, but especially
pathology. Incidentally, it was only these developments that created